Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Ichor Holdings
ICHR
$2.56B
| $14.4M | ﹤0.01% |
536,603
+19,879
| +4% | +$531K |
|
2002
Collegium Pharmaceutical
COLL
$956M
| $14.4M | ﹤0.01% |
618,917
+13,225
| +2% | +$267K |
|
2003
Icon
ICLR
$12.7B
| $14.3M | ﹤0.01% |
73,872
+259
| +0.4% | +$51.4K |
|
2004
TPG
TPG
$7.86B
| $14.3M | ﹤0.01% |
514,778
+29,885
| +6% | +$941K |
|
|
PAYA
2005
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $14.3M | ﹤0.01% |
1,819,580
+45,403
| +3% | +$350K |
|
2006
Myers Industries
MYE
$1.29B
| $14.3M | ﹤0.01% |
644,171
+14,818
| +2% | +$308K |
|
2007
Univest Financial
UVSP
$1.18B
| $14.3M | ﹤0.01% |
547,183
+10,070
| +2% | +$270K |
|
2008
National Healthcare
NHC
$3.38B
| $14.3M | ﹤0.01% |
239,997
+8,640
| +4% | +$524K |
|
|
HOUS
2009
DELISTED
Anywhere Real Estate
HOUS
| $14.3M | ﹤0.01% |
2,234,187
-37,137
| -2% | -$268K |
|
|
RWT
2010
Redwood Trust
RWT
$594M
| $14.3M | ﹤0.01% |
2,110,697
-26,791
| -1% | -$187K |
|
2011
Caleres
CAL
$487M
| $14.3M | ﹤0.01% |
640,170
+12,625
| +2% | +$310K |
|
|
OPI
2012
DELISTED
Office Properties Income Trust
OPI
| $14.3M | ﹤0.01% |
1,067,970
+24,598
| +2% | +$354K |
|
2013
Metallus
MTUS
$898M
| $14.2M | ﹤0.01% |
782,109
+10,492
| +1% | +$186K |
|
2014
Hanmi Financial
HAFC
$946M
| $14.2M | ﹤0.01% |
573,339
+17,235
| +3% | +$439K |
|
|
UHT
2015
Universal Health Realty Income Trust
UHT
$594M
| $14.2M | ﹤0.01% |
297,230
-548
| -0.2% | -$26.4K |
|
|
INBX
2016
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $14.2M | ﹤0.01% |
575,697
+78,890
| +16% | +$2.32M |
|
2017
Heartland Express
HTLD
$956M
| $14.1M | ﹤0.01% |
922,122
+21,401
| +2% | +$330K |
|
|
OSG
2018
Octave Specialty Group
OSG
$222M
| $14.1M | ﹤0.01% |
810,842
+12,564
| +2% | +$187K |
|
2019
Cogent Biosciences
COGT
$7.24B
| $14.1M | ﹤0.01% |
1,222,330
+47,570
| +4% | +$589K |
|
|
MORF
2020
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $14.1M | ﹤0.01% |
527,235
+24,285
| +5% | +$664K |
|
2021
Ubiquiti
UI
$34.3B
| $14.1M | ﹤0.01% |
51,433
-4,776
| -8% | -$1.42M |
|
2022
Hims & Hers Health
HIMS
$7.31B
| $14.1M | ﹤0.01% |
2,193,273
+76,928
| +4% | +$438K |
|
|
CUTR
2023
DELISTED
Cutera, Inc.
CUTR
| $14M | ﹤0.01% |
317,000
+11,963
| +4% | +$545K |
|
|
PRVB
2024
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $14M | ﹤0.01% |
1,322,189
+125,392
| +10% | +$1.01M |
|
|
ZUO
2025
DELISTED
Zuora, Inc.
ZUO
| $14M | ﹤0.01% |
2,195,227
+83,964
| +4% | +$594K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.